Coronary computed tomographic angiography (CTA) has high sensitivity and excellent negative predictive value to Background-Coronary computed tomographic angiography (CTA) and myocardial perfusion imaging (CTP) is a validated approach for detection and exclusion of flow-limiting coronary artery disease (CAD), but little data are available on gender-specific performance of these modalities. In this study, we aimed to evaluate the diagnostic accuracy of combined coronary CTA and CTP in detecting flow-limiting CAD in women compared with men. Methods and Results-Three hundred and eighty-one patients who underwent both CTA-CTP and single-photon emission computed tomography myocardial perfusion imaging preceding invasive coronary angiography as part of the CORE320 multicenter study (Coronary Artery Evaluation Using 320-row Multidetector Computed Tomography Angiography and Myocardial Perfusion) were included in this ancillary study. All 4 image modalities were analyzed in blinded, independent core laboratories. Prevalence of flow-limiting CAD defined by invasive coronary angiography equal to 50% or greater with an associated single-photon emission computed tomography myocardial perfusion imaging defect was 45% (114/252) and 23% (30/129) in males and females, respectively. Patient-based diagnostic accuracy defined by the area under the receiver operating curve for detecting flow-limiting CAD by CTA alone in females was 0.83 (0.75-0.89) and for CTA-CTP was 0.92 (0.86-0.97; P=0.003) compared with men where the area under the receiver operating curve for detecting flow-limiting CAD by CTA alone was 0.82 (0.77-0.87) and for CTA-CTP was 0. 84 (0.80-0.89; P=0.29). Conclusions-The combination of CTA-CTP was performed similarly in men and women for identifying flow-limiting coronary stenosis; however, in women, CTP had incremental value over CTA alone, which was not the case in men. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00934037.
C oronary artery disease (CAD) is the leading cause of death for both men and women in the United States 1 ; however, there are important differences in gender-related risk factors, diagnosis, and management of ischemic heart disease (IHD). [2] [3] [4] [5] [6] [7] [8] Women tend to have lower rates of obstructive CAD, pointing to an increased role of other factors, such as microvasculature dysfunction, and increasing the need for gender-specific data to inform the management of women with suspected or known IHD. [9] [10] [11] Gender CTA and CTP exclude significant CAD, especially in the intermediate-to low-risk groups. [12] [13] [14] [15] In a recent analysis from the PROMISE study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain), Pagidipati et al 16 report that CTA was superior to stress testing in providing prognostic information for women; however, in men, the prognostic power was similar for stress testing and CTA. The 2014 American Heart Association report on the role of noninvasive testing in women includes coronary CTA in the diagnostic evaluation of women with suspected IHD, but calls for more evidence in the role of myocardial computed tomography perfusion (CTP). 17 Previous results of the CORE320 trial (Coronary Artery Evaluation Using 320-Row Multidetector Computed Tomography Angiography and Myocardial Perfusion) showed that the combination of CTA and CTP accurately identifies patients with flow-limiting coronary lesions 18 ; however, the diagnostic accuracy of the combination of coronary CTA and CTP in women compared with men is not known. A recent meta-analyses reported that the diagnostic accuracy of single-photon emission computed tomography (SPECT) was similar for both men and women. 19 The objective of this study was to compare the genderspecific diagnostic accuracy of CTA and combined CTA-CTP to predict flow-limiting coronary stenosis, defined as stenosis of at least 50% by invasive coronary angiography (ICA) and a perfusion defect on SPECT, as well as significant stenosis by ICA alone. Additional analyses were done to evaluate and compare the gender-specific diagnostic accuracy of SPECT.
Methods
CORE320 is a multicenter, multinational, prospective, institutional review board-approved study performed in 8 countries at 16 centers. Study participants provided informed consent, and institutional review board approval was obtained by a central institutional review board and local institutional review board at all centers. The primary objectives of the CORE320 trial were to assess the accuracy of coronary CTA and CTP in identifying coronary stenosis (≥50%) by ICA with a corresponding myocardial perfusion defect on SPECT. 20 The study design has been previously published in detail. 20 In short, the study enrolled patients 45 to 85 years of age with suspected or known CAD referred for ICA. All patients had a SPECT/myocardial perfusion imaging (performed clinically or as part of research protocol), ICA, adenosine stress CTP, and coronary CTA performed in a CORE320-validated laboratory. 20 Women of childbearing potential had a negative pregnancy test within 24 hours before computed tomography. 20 Computed tomographic image acquisition has been previously described in detail. 15, [20] [21] [22] All CTA and CTP images were reconstructed, processed, and interpreted by 2 blinded core laboratories. 18, 19 As previously described, a summed stress score ≥2 for CTP and ≥1 for SPECT was considered positive using a 13-segment myocardial model. 21, 22 Clinically indicated ICA was performed within 60 days of the combined CTA-CTP acquisition, and lesion severity was determined by quantitative coronary angiography methods as previously described. 15 SPECT and ICA images were interpreted in blinded core laboratories using previously described methods.
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Statistical Analysis
Patient characteristics were compared according to gender using Pearson's chi square or Wilcoxon rank-sum test as appropriate and reported as median and percent or interquartile range and P value. The primary analysis of diagnostic accuracy was performed on a perpatient level using area under the receiver operating characteristics (AUC) curves to compare the ability of CTA and CTA-CTP to predict flow-limiting stenosis, stenosis ≥50% by ICA plus corresponding perfusion defect on SPECT, and stenosis ≥50% by ICA alone according to gender. The combination of CTA-CTP was considered positive if there was a ≥50% stenosis with corresponding perfusion defect on CTP with a summed stress score ≥2. The combination of ICA and SPECT was considered positive if there was a ≥50% stenosis with corresponding perfusion defect on SPECT with a summed stress score ≥1. Additional analysis included sensitivity, specificity, positive predictive value, and negative predictive value calculations to determine the performance of combination CTA-CTP to predict flow-limiting stenosis according to gender. The same parameters were also calculated to evaluate SPECT and CTA alone to predict stewnosis ≥50% by ICA according to gender. Point statistics in males and females were all compared using 2-sample tests for binomial proportions. Statistical analyses were performed by the CORE320 Statistical Core Laboratory at the Johns Hopkins Bloomberg School of Public Health using SAS 9.3, Stata 13, and SPlus 8.2. All tests were 2-sided, and a P value of <0.05 was considered statistically significant.
Results
Of 381 patients enrolled who satisfactorily completed all imaging procedures without technical limitations, 33.9% (n=129) were female and 66.1% (n=252) were male. Baseline characteristics according to gender are shown in Table 1 . Compared with men, women tended to be younger, had lower body mass index, and were less likely to smoke or have a previous history of CAD (confirmed by either history of documented myocardial infarction or percutaneous coronary intervention CAD indicates coronary artery disease; CTA, computed tomographic angiography; CTP, computed tomographic myocardial perfusion imaging; ICA, invasive coronary angiography; IQR, interquartile range; NYHA, New York Heart Association; and SPECT, single-photon emission computed tomography. Table 1 . Continued Gender CTA and CTP also had a lower creatinine compared with men and were less likely to be on an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker. Notably, women tended to be in lower cardiovascular risk category compared with men according to Diamond Forrester score and had a lower Agatston calcium score. Women also received less contrast and radiation compared with men for CTA, CTP, and SPECT (Table 1) .
Diagnostic Performance of Combined Coronary CTA and Myocardial CTP According to Gender
The combination of CTA-CTP was 87% sensitive (95% confidence interval [CI] 0.69-0.96) and 74% specific (95% CI 0.64-0.82) in identifying women with flow-limiting CAD (Table 2 ; confusion matrix depicted in Table I in the Data Supplement). Compared with men, the specificity of CTA-CTP was significantly higher in women (AUC 0.74; 95% CI 0.64-0.82 versus 0.44; 95% CI 0.36-0.53; P<0.0001; Table 2 ).
For the primary study end point, the AUC for combined CTA-CTP was 0. Receiver operating characteristic (ROC) curve and corresponding area under the curve (AUC) comparing the diagnostic performance of combined computed tomographic angiography (CTA) and computed tomographic myocardial perfusion (CTP) by gender to identify a ≥50% coronary stenosis and a corresponding myocardial perfusion using the reference standard of invasive coronary angiography (ICA) and single photon emission computed tomography myocardial perfusion imaging (SPECT/MPI) at a patient level. Gender CTA and CTP CI 0.75-0.89) for CTA alone (P=0.003; Figure 2A ). There was no significant difference in the AUC of CTA-CTP compared with CTA alone for the detection of flow-limiting CAD in men ( Figure 2B) . Similarly, the AUC for combined CTA-CTP to detect a ≥70% stenosis by ICA plus corresponding perfusion defect on SPECT was 0.92 (95% CI 0.88-0.97) in females versus 0.86 (95% CI 0.81-0.91) in males (P=0.06) for the detection of flow-limiting stenosis (Table II in the Data  Supplement) .
The combination of CTA-CTP to predict stenosis ≥50% by ICA performed similarly in males and females (AUC 0.90; 95% CI 0.86-0.96 for women versus 0.88; 95% CI 0.84-0.93 for men; P=0.48; Figure 3A ).
Diagnostic Performance of CTA According to Gender
The specificity of coronary CTA for detecting a stenosis ≥50% by ICA was significantly higher in women than in men (86% in women versus 63% in men; P=0.002; Table 2 ; confusion matrix depicted in Table III in the Data Supplement). The AUC, however, was similar between women and men (AUC 0.91; 95% Figure 3B ). CTA significantly outperformed SPECT in predicting ≥50% stenosis by ICA. In females, the AUC was 0.91 (95% CI 0.85-0.96) compared with 0.71 (95% CI 0.62-0.78) for SPECT (P=0.0001). Again, a similar trend was noted in males, where the AUC was 0.89 (95% CI 0.84-0.92) for CTA compared with 0.66 (95% CI 0.60-0.72) for SPECT alone (P<0.0001).
Discussion
The CORE320 study provided prospective multicenter, multinational, comprehensive analyses to define the contribution of CTP imaging over and above the established role of CTA, 17 and the present study is the first multicenter study to evaluate gender differences. In this analysis, we demonstrated that both CTA and CTA-CTP performed similarly in women and men for detecting flow-limiting CAD; however, the combination of CTA-CTP significantly outperformed CTA alone in improving specificity in women and not in men.
Our study shows that CTP has incremental value over CTA alone in women, which was not the case in men. We suspect that this is related to the underlying differences in IHD in women. Women not only present differently from men, but also undergo different diagnostic evaluation and therapeutic management. [3] [4] [5] [6] [7] [8] 23 Women tend to be older than men on average and have more comorbidities at the time of presentation. 3, 8 They also are less likely to undergo noninvasive testing, coronary angiography, and revascularization. [3] [4] [5] [6] [7] [8] [24] [25] [26] Microvascular dysfunction and diffuse coronary atherosclerosis without obstructive lesions are more prevalent in women than in men. [9] [10] [11] In our study, more women were referred for invasive angiography without having a noninvasive stress test, which supports the notion that accurate classification of symptoms for women is challenging. The lower prevalence of obstructive epicardial CAD and different presenting symptoms of females in combination with fewer performed noninvasive testing likely contributes to their delayed diagnosis and high mortality. 27 These gender-related differences in IHD may be the reason for the incremental diagnostic value of CTP in women.
Previous studies evaluating the diagnostic performance of coronary CTA in women compared with men have shown discordant results. While one study showed lower specificity, 28 another showed lower accuracy and higher rates of nondiagnostic exams. 29 Other studies have shown no difference in accuracy, including ACCURACY multicenter trial (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography). 30 We also found no statistically significant difference in overall accuracy for coronary CTA; however, we found higher specificity in women, which is likely secondary to lower disease prevalence in women.
Limiting exposure to ionizing radiation is an important consideration in choosing a diagnostic modality, particularly in women. 31 Despite significant worldwide variation in best practice use and radiation doses from nuclear cardiology procedures, only small differences were observed between genders worldwide. 32 In this study, the median radiation exposure in women was on average 7.97 mSv lower for CTA than SPECT and 2.81 mSv lower for the combination of CTA-CTP than SPECT. CTA and CTA-CTP exposed women to lower radiation than SPECT.
Limitations
We acknowledge that our study has several limitations. Because this is a secondary analysis of the CORE320 cohort, it was not designed to evaluate gender-specific differences, and given the lower disease prevalence in women (23%) compared with men (45%), we may underestimate or be limited in our ability to detect small differences. Second, 10 patients had incomplete CTP imaging (6 lack of contrast enhancement and 4 had incomplete anatomy in the images) and were excluded from this study. Third, breast attenuation may limit the interpretation of SPECT in this study, and new algorithms such as attenuation correction, which can mitigate these artifacts, were not available on all systems used in this study. Finally, there are many nontraditional risk factors that increase the risk of IHD in women, including estrogen status, history of polycystic ovary syndrome, history of hypertensive disease during pregnancy, 33 placental syndrome in combination with poor fetal growth or intrauterine death, 34 and gestational diabetes mellitus, which greatly increases the relative risk of developing type 2 diabetes mellitus. 35 We do not have baseline characteristics to further evaluate females with specific risk factors; however, given the relative infrequency of some of these risk factors, it was not practical to obtain.
Conclusions
CTP had an incremental diagnostic value compared with CTA alone in identifying flow-limiting stenosis in women, but not in men, which is likely related to underlying differences in the pathophysiology of IHD in women. 
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